Literature DB >> 6973591

A radioactive antigen-binding assay for the measurement of antibody to Haemophilus influenzae type b capsular polysaccharide.

J S Kuo, N Monji, R S Schwalbe, D W McCoy.   

Abstract

A new polyethylene glycol (PEG) radioimmunoprecipitation assay was developed for the detection of antibody to Haemophilus influenzae b capsular polysaccharide, polyribosylribitol phosphate (PRP). The radioactive antigen, [3H]PRP, with a high specific activity, was produced by growing the organism in the presence of [3H]ribose and was purified by hydroxylapatite and Sepharose 4B column chromatography. In the assay, PEG (12.5%) was used to separate antibody-bound [3H]PRP from free [3H]PRP. The assay covered the range of 0.5 and 20 ng antibody/assay at a maximum sensitivity of 0.5 approximately 1.0 ng antibody/assay. With various dilutions (1-20 ng antibody/assay) of S. Klein reference antiserum, the within-run coefficient of variation (CV) of 10 replicates ranged from 3.5 to 8.5%. Average CVs of 8.9% and 11.0% were obtained in the between-run and day-to-day reproducibility studies. The binding of [3H]PRP to S. Klein reference antiserum was severely inhibited by a minute amount of non-radioactive PRP; however, no significant interference was found in the presence of high concentrations of polysaccharides from Escherichia coli K100 and Streptococcus pneumoniae indicating that the RIA was highly specific for antibody to H. influenzae b PRP. The present RIA is a simple, specific, sensitive and reproducible procedure for the evaluation of antibody responses of young animals and infants to H. influenzae b vaccines and infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973591     DOI: 10.1016/0022-1759(81)90034-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b.

Authors:  M Mariani; E Luzzi; D Proietti; S Mancianti; D Casini; P Costantino; P van Gageldonk; G Berbers
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  Relationship of health-related variables to levels of anti-polyribosylribitol phosphate antibodies in adults.

Authors:  W M McDonnell; J R Gilsdorf; J B Kent; J N Sheagren
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

3.  Comparison of methods for serotyping isolates of Haemophilus influenzae.

Authors:  C A Himmelreich; S J Barenkamp; G A Storch
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

4.  Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates.

Authors:  R S Munson; J L Shenep; S J Barenkamp; D M Granoff
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate.

Authors:  N Monji; M R Stebbins; D W McCoy; J S Kuo
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

6.  Epidemiology of Haemophilus influenzae type B disease among Navajo Indians.

Authors:  J L Coulehan; R H Michaels; C Hallowell; R Schults; T K Welty; J S Kuo
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

7.  Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b.

Authors:  R S Munson; D M Granoff
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

8.  Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.

Authors:  N A Halsey; T L Johansen; L C Bowman; M P Glode
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.

Authors:  N P Steele; R S Munson; D M Granoff; J E Cummins; R P Levine
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

10.  Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.

Authors:  J L Shenep; R S Munson; S J Barenkamp; D M Granoff
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.